Clinical Trial: Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of Nasonex® (Mometasone Furoate Nasal Spray(MFNS)) in the treatment of nasal polyps in pediatric subjects between the ages of 6 and less than 18 years old. Safety will be the primary focus of this study.
Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.
Current Primary Outcome: Change From Baseline 24-hour Urinary Free Cortisol Level [ Time Frame: Baseline to Endpoint ]
Original Primary Outcome:
Current Secondary Outcome: Change From Baseline 24-hour Urinary Free Cortisol Level Corrected for Creatinine [ Time Frame: Baseline to Endpoint ]
Original Secondary Outcome:
Information By: Merck Sharp & Dohme Corp.
Dates:
Date Received: September 18, 2006
Date Started: July 2006
Date Completion:
Last Updated: March 13, 2017
Last Verified: March 2017